---
$id: https://graph.org.ai/products/commodity/51343116
$type: Product
source: UNSPSC
code: "51343116"
title: "Azidothymidine or zidovudine"
class: "51343100"
classTitle: "Antiviral pyrimidines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Azidothymidine or zidovudine

**UNSPSC Code**: 51343116
**Class**: [Antiviral pyrimidines](Antiviral pyrimidines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B9XT59T7S. European Medicines Agency schedules Zidovudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00153MIG. Zidovudine generally arises in the molecular formula C10H13N5O4. The term ZIDOVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) ZIDOVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Azidothymidine or zidovudine bears US NLM identifiers UMLS ID C0043474 and NCI Concept Code C947. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-].

